Medscape | Biologicals Improve RA Function More Than Other DMARDs Medscape The trials included abatacept, adalimumab, certolizumab, etanercept, golimumab, infliximab, or rituximab compared with either nbDMARDs or placebo. The main outcome measure was improvement in physical function measured by change in Health ... |
